Participants enrolled in Detroit Research on Cancer Survivors (Detroit ROCS)
Diagnosis of Primary Breast, prostate, or colorectal cancer on or after 1/1/2013
have received or currently receiving care at Karmanos Cancer Institute
meet one or more of the National Comprehensive Cancer Network (NCCN) guidelines for cancer genetic testing as described below
Female breast
1. personal diagnosis at age ≤50
2. personal history of the triple-negative subtype
3. at least 1 close (first- or second-degree) relative diagnosed with breast cancer at age \<50
4. at least 1 close relative diagnosed with ovarian cancer
5. 2+ close relatives diagnosed with breast or prostate cancer
6. age \<50 AND another primary breast cancer at any age
7. 2+ primary breast cancers at any age
OR Prostate
1. personal history of high-risk or very high-risk prostate cancer
2. personal history of regional or metastatic prostate cancer
3. personal history of less than high-risk prostate cancer with a suggestive family history (i.e., father or brother or multiple relatives with prostate cancer diagnosed at age \<60; at least 1 relative with breast, ovarian, or pancreatic cancer; or at least 1 relative with colorectal, ovarian, pancreatic, or kidney cancer)
OR Colorectal
1. personal diagnosis at age ≤50
2. at least 1 close relative diagnosed with HNPCC at age \<50
3. at least 2 close relatives diagnosed with an HNPCC cancer at any age
4. colorectal and \>=1 primary endometrial, ovarian, gastric, pancreatic, or prostate
